Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04646668 · ClinicalTrials.gov registry record · NA

Comparative Abuse Liability Among African American and White Smokers

A NA study, sponsored by University of Kansas Medical Center.

Completed
Registry status
NA
Development phase
22
Enrollment target

NCT04646668: Completed NA study, sponsored by University of Kansas Medical Center.

NCT04646668 is a NA study that has completed, run by University of Kansas Medical Center. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04646668, a NA study, has completed, sponsored by University of Kansas Medical Center.

COMPLETED
Registry status
NA
Development phase
22 participants
Enrollment target

Study Summary

The study is a randomized crossover trial. Current smokers will complete a session with each product: usual brand cigarette, e-cigarette, and heat-not-burn. The objective of this survey is to assess for ongoing use of study products and is part of safety monitoring.

Primary Outcome

Blood plasma nicotine concentration after 10 puff bout of product at 5 minutes

Interventions

  • COMBINATION_PRODUCT E-cigarette and Heat not burn

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2020-09-21
Est. Completion 2021-08-26
Phase NA
University of Kansas Medical Center

408 total trials

What the finished NCT04646668 record still lists

NCT04646668 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 1 intervention - of which E-cigarette and Heat not burn is the first listed.

NCT04646668 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04646668 about?

NCT04646668 is a clinical study titled "Comparative Abuse Liability Among African American and White Smokers". The study is a randomized crossover trial. Current smokers will complete a session with each product: usual brand cigarette, e-cigarette, and heat-not-burn. The objective of this survey is to assess for ongoing use of study products and is part of safety monitoring.

What is the current status of trial NCT04646668?

This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2020-09-21. Estimated completion is 2021-08-26.

What interventions are being tested in trial NCT04646668?

The interventions under investigation include: E-cigarette and Heat not burn (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT04646668?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04646668's enrollment target sits among peer trials

22 1756th of 2000 higher than 239 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02508038 · 22 participants · Phase 1

    Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors

  • NCT03099356 · 22 participants · Phase 2

    Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer

  • NCT03676647 · 22 participants

    Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules

  • NCT04569591 · 22 participants · NA

    DDAVP for Pituitary Adenoma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04646668, the US trial registry maintained by the National Library of Medicine. NCT04646668 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.